D&D Pharmatech has linked its GLP-1/glucagon dual receptor agonist to improvements in liver health, keeping the Korean ...
The Chosun Ilbo on MSN
K-Bio targets MASH market after obesity success
K-bio companies are targeting metabolic dysfunction-associated steatohepatitis (MASH) treatments as the next growth driver ...
Farrell also appeared in a number of other television shows and films, including “Starsky and Hutch,” “Billy Jack Goes to Washington,” “The Towering Inferno” and “Coffy.” Beyond acting, in 1980, ...
Meena Bansal, MD, discusses the evolving MASH pipeline and why precision phenotyping, biomarkers, and cardiovascular outcomes ...
Altimmune announces IMPACT phase 2b data from pemvidutide; shows significant metabolic improvements in patients with MASH: Gaithersburg, Maryland Saturday, May 30, 2026, 16:00 Hrs ...
MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...
What Are Clinical Trials for MASH? Clinical trials for MASH are research studies that evaluate potential new treatments for a form of liver disease called metabolic dysfunction-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results